Sherry Y.

Vp, CMC Biologics at Centessa Pharmaceuticals

Sherry Y. has a diverse and extensive work experience spanning over two decades. Sherry is currently serving as the VP of CMC Biologics at Centessa Pharmaceuticals since February 2022. Prior to this, they worked as an entrepreneur in the life science sector at Stealth from April 2021 to January 2022.

From 2015 to 2021, Sherry held various roles at WuXi Biologics, starting as a Director and eventually becoming a Senior Director of CMC Management. During their time there, they managed over ten biologics CMC programs, leading process, analytical, and formulation development. Sherry played a crucial role in driving the delivery of projects on time and within budget, resolving technical, operational, quality, and regulatory challenges.

Before joining WuXi Biologics, they worked as a Consultant in the Life Sciences Sector from September 2011 to June 2015. Prior to that, they had a brief stint as a Summer Associate in Healthcare Investment at Warburg Pincus.

Sherry's academic background includes being a Sloan Fellow in Innovation and Global Leadership at MIT Sloan School of Management from June 2009 to May 2011. During this time, they focused on operations management, business strategy, and finance, and conducted due diligence for a biotechnology innovation at MIT.

Sherry'searlier career includes roles at Wyeth Biotech as a Process Engineer to Senior Technology Engineer from September 2003 to May 2006, where they successfully led multiple projects and implemented process improvements. Sherry also worked as a Process Engineer at Analog Devices from September 1996 to October 2002, where they managed integrated transistor development projects and provided critical technical leadership.

Overall, Sherry Y. has a strong track record of success in the biopharmaceutical industry, demonstrating leadership skills, problem-solving abilities, and a strategic mindset.

Sherry Y. holds a Ph.D. in Chemical Engineering from the University of Michigan, which they obtained from 1991 to 1996. Prior to that, they completed their Master's degree in Chemistry at the University of Michigan from 1989 to 1991. Sherry began their education journey by earning a Bachelor's degree in Chemical Physics from the University of Science and Technology of China, where they studied from 1984 to 1989. Later on, Sherry Y. pursued their M.B.A. in Innovation and Global Leadership at the MIT Sloan School of Management, graduating from 2009 to 2011.

Links

Previous companies

WuXi Biologics logo
Analog Devices logo
Pfizer logo
Warburg Pincus logo

Org chart

Timeline

  • Vp, CMC Biologics

    February, 2022 - present